Evotec, Second Genome to collaborate on finding treatments for microbiome-mediated diseases

By Zachary Brennan

- Last updated on GMT

Evotec, Second Genome to collaborate on finding treatments for microbiome-mediated diseases

Related tags Evotec Partnership

Evotec and Second Genome have agreed to partner in small molecule-based discovery and development activities for the treatment of microbiome-mediated diseases. 

The collaboration will work to identify novel compounds as well as licence agreements for already existing assets developed by Evotec. Second Genome's approach to identify and modulate microbiome-mediated pathways will be enhanced by Evotec's integrated drug discovery platform. The agreement triggers an undisclosed upfront payment for Evotec, which is also eligible for pre-clinical, clinical and regulatory milestones as well as royalty payments related to commercialisation.

The microbiome field is new to Evotec, but Second Genome is an expert on this field​,” Evotec spokesman Gabriele Hansen told Outsourcing-Pharma.com.

As part of the partnership, Second Genome and Evotec will work together to screen microbiome-mediated targets of interest identified by the Second Genome microbiome discovery platform with Evotec's technology platform, chemical libraries and other pre-clinical capabilities.

Dr Cord Dohrmann, Chief Scientific Officer of Evotec, said in a statement: "We are pleased to contribute to Second Genome's unique approach to treat microbiome-mediated diseases in the body with a particular emphasis on the gut​."

This latest deal for Evotec is just one of a flurry of recent partnerships that the company has formed. Earlier this year, Padlock Therapeutics extended its relationship with Evotec​ after prior success, and the European CRO also saw successes from its partnerships with Bayer and Janssen​. Evotec also entered into negotiations in December for a major strategic relationship with Sanofi​ that could be worth more than $300m.

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

Related suppliers

Follow us

Products

View more

Webinars